
### [NCIT:C9295](http://purl.obolibrary.org/obo/NCIT_C9295)
**Label:** Mast Cell Neoplasm

**Subclasses:** [NCIT:C3169](http://purl.obolibrary.org/obo/NCIT_C3169) (Mast Cell Leukemia), [NCIT:C3217](http://purl.obolibrary.org/obo/NCIT_C3217) (Benign Mastocytoma), [NCIT:C43284](http://purl.obolibrary.org/obo/NCIT_C43284) (Primary Systemic Mastocytosis), [NCIT:C9303](http://purl.obolibrary.org/obo/NCIT_C9303) (Mastocytoma), [NCIT:C84269](http://purl.obolibrary.org/obo/NCIT_C84269) (Mastocytosis), [NCIT:C9348](http://purl.obolibrary.org/obo/NCIT_C9348) (Mast Cell Sarcoma), [NCIT:C7137](http://purl.obolibrary.org/obo/NCIT_C7137) (Cutaneous Mastocytosis), [NCIT:C43277](http://purl.obolibrary.org/obo/NCIT_C43277) (Pure Cutaneous Mastocytosis), [NCIT:C9235](http://purl.obolibrary.org/obo/NCIT_C9235) (Systemic Mastocytosis), [NCIT:C7136](http://purl.obolibrary.org/obo/NCIT_C7136) (Extracutaneous Mastocytoma), [NCIT:C8991](http://purl.obolibrary.org/obo/NCIT_C8991) (Malignant Mastocytosis), [NCIT:C9286](http://purl.obolibrary.org/obo/NCIT_C9286) (Indolent Systemic Mastocytosis), [NCIT:C9284](http://purl.obolibrary.org/obo/NCIT_C9284) (Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN)), [NCIT:C9285](http://purl.obolibrary.org/obo/NCIT_C9285) (Aggressive Systemic Mastocytosis), 

**Class expressions from DL-Learner:**

- Thing 55.02%
- [NCIT:C43257](http://purl.obolibrary.org/obo/NCIT_C43257) (Unifocal Disease) 52.63%
- [NCIT:C43285](http://purl.obolibrary.org/obo/NCIT_C43285) (Unifocal Disease at Presentation) 51.32%
- [NCIT:C39692](http://purl.obolibrary.org/obo/NCIT_C39692) (Complete Spontaneous Regression) 51.32%
- [NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease) 51.32%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 51.32%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 51.32%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 51.32%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 45.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) 43.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 43.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 43.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 43.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 43.46%
- [NCIT:C36162](http://purl.obolibrary.org/obo/NCIT_C36162) (Localized Disease) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 43.46%


